Serum BAFF is particularly strongly upregulated in patients with pSS with lymphoproliferative disorders [15], and in patients with systemic lupus erthyematosus and rheumatoid arthritis [53–55]. This evidence concerns the gene TNFSF13B and rheumatoid arthritis.